Video Experimental Relacionado
Updated: Jul 27, 2026

07:08
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
Vitamina E y función neurológica
Lancet (London, England)
|January 29, 1983
Resumen
La vitamina E es crucial para la salud neurológica. La suplementación puede prevenir y revertir el daño nervioso causado por la deficiencia de vitamina E en varias condiciones.
Área de la Ciencia:
- Neurología Neurología.
- Ciencias de la Nutrición Ciencias de la Nutrición
Sus antecedentes:
- La deficiencia de vitamina E puede conducir a complicaciones neurológicas graves.
- Los trastornos de malabsorción de grasas a menudo se asocian con la deficiencia de vitamina E.
Objetivo del estudio:
- Para resaltar el papel crítico de la vitamina E en el mantenimiento de la función neurológica normal.
- Revisar la evidencia que apoya el potencial terapéutico de la vitamina E en trastornos neurológicos.
Principales métodos:
- Revisión de la evidencia clínica de pacientes con abetalipoproteinaemia.
- Análisis de casos que involucran otros trastornos de malabsorción de grasa con deficiencia de vitamina E.
- Comparación de los hallazgos neuropatológicos humanos con modelos animales de deficiencia de vitamina E.
Principales resultados:
- La terapia temprana de vitamina E en la abetalipoproteineemia retrasa o previene los problemas neurológicos.
- El tratamiento con vitamina E puede detener o revertir la neuropatía en casos establecidos.
- Las manifestaciones neurológicas en otros trastornos de malabsorción de grasa mejoran con la vitamina E.
- Los cambios neuropatológicos en los seres humanos reflejan los de los animales con deficiencia de vitamina E.
Conclusiones:
- La vitamina E es esencial para la función neurológica humana normal.
- La intervención terapéutica con vitamina E puede mitigar o resolver los déficits neurológicos.
- Los modelos animales replican efectivamente las neuropatías humanas relacionadas con la deficiencia de vitamina E.
Videos de Conceptos Relacionados
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Vitamins
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

